Posted by Michael Wonder on 04 Aug 2022
Pear Therapeutics and Cove Behavioral Health to provide patients access to prescription digital therapeutic for the treatment of opioid use disorder
3 August 2022 - Pear Therapeutics announced today that Cove Behavioral Health will provide access to Pear’s FDA authorised PDT reSET-O for the treatment of opioid use disorder.
Cove Behavioral Health, a comprehensive community based substance use disorder service provider, is implementing reSET-O in its centres in Tampa Bay, Florida for eligible patients.
Funding is provided by the State Opioid Response grant, administered by Central Florida Behavioral Health Network, and part of the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration SOR grant program for people in need of prevention, treatment and recovery support for opioid use disorder.
